These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1034 related items for PubMed ID: 3335601

  • 21. Thyrotropin receptor antibodies and Graves' disease, a side-effect of 131I treatment in patients with nontoxic goiter.
    Nygaard B, Knudsen JH, Hegedüs L, Scient AV, Hansen JE.
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2926-30. PubMed ID: 9284721
    [Abstract] [Full Text] [Related]

  • 22. Graves' disease: diagnostic and therapeutic challenges (multimedia activity).
    Kahaly GJ, Grebe SK, Lupo MA, McDonald N, Sipos JA.
    Am J Med; 2011 Jun; 124(6):S2-3. PubMed ID: 21605717
    [Abstract] [Full Text] [Related]

  • 23. Pretreatment with betamethasone of patients with Graves' disease given radioiodine therapy: thyroid autoantibody responses and outcome of therapy.
    Gamstedt A, Karlsson A.
    J Clin Endocrinol Metab; 1991 Jul; 73(1):125-31. PubMed ID: 2045463
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Triiodothyronine generation from thyroxine in human thyroid: enhanced conversion in Graves' thyroid tissue.
    Ishii H, Inada M, Tanaka K, Mashio Y, Naito K, Nishikawa M, Imura H.
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1211-7. PubMed ID: 6894450
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. An elevation of serum immunoglobulin E provides a new aspect of hyperthyroid Graves' disease.
    Yamada T, Sato A, Komiya I, Nishimori T, Ito Y, Terao A, Eto S, Tanaka Y.
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2775-8. PubMed ID: 10946880
    [Abstract] [Full Text] [Related]

  • 32. Transient recurrence of hyperthyroidism after delivery in Graves' disease.
    Amino N, Miyai K, Yamamoto T, Kuro R, Tanaka F.
    J Clin Endocrinol Metab; 1977 Jan; 44(1):130-6. PubMed ID: 576228
    [Abstract] [Full Text] [Related]

  • 33. Administration of additional inactive iodide during radioiodine therapy for Graves' disease: who might benefit?
    Dietlein M, Moka D, Reinholz U, Schmidt M, Schomäcker K, Schicha H, Wellner U.
    Nuklearmedizin; 2007 Jan; 46(3):77-84. PubMed ID: 17549318
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Fluctuations in the titers of anti-thyroid hormone and anti-thyroglobulin antibodies in 4 cases of Graves' disease during long-term treatment period].
    Komaki T, Sakata S, Nakamura S, Matsuda M, Kojima N, Takuno H, Miura K.
    Nihon Naibunpi Gakkai Zasshi; 1989 Jul 20; 65(7):627-39. PubMed ID: 2583311
    [Abstract] [Full Text] [Related]

  • 38. Serum thyroid-stimulating antibody, thyroglobulin levels, and thyroid suppressibility measurement as predictors of the outcome of combined methimazole and triiodothyronine therapy in Graves' disease.
    Werner RS, Romaldini JH, Farah CS, Werner MC, Bromberg N.
    Thyroid; 1991 Jul 20; 1(4):293-9. PubMed ID: 1688155
    [Abstract] [Full Text] [Related]

  • 39. Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3'5-triiodothyronine (T3).
    Chopra IJ, Williams DE, Orgiazzi J, Solomon DH.
    J Clin Endocrinol Metab; 1975 Nov 20; 41(5):911-20. PubMed ID: 1242390
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 52.